EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Temporal Trends in HIV-1 Subtypes and Antiretroviral Drug Resistance Mutations in Istanbul, Türkiye (2021–2024): A Next-Generation Sequencing Study

Murat Yaman iD, Begüm Saran Gülcen iD, Kübra Özgüler iD, Muammer Osman Köksal iD, Serap Demir Tekol iD, Arzu İlki iD

Viruses · 2025

DOI: 10.3390/v17040478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Murat Yaman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Microbiology, Marmara University Pendik Research and Training Hospital, Istanbul 34899, Türkiye. Hauptthemen laut MEDLINE: HIV-1, Drug Resistance, Viral, HIV Infections, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV-1 genotyping and drug resistance tests are routinely performed in virology laboratories in some countries, aiding clinical management. In Istanbul, between January 2021 and March 2024, plasma samples from 1029 HIV-1-infected patients were analyzed using the NGS method, and mutation and drug resistance results were retrospectively evaluated alongside demographic data. Subtype B (54.4%) was most frequent in Turkish patients, while Subtype A1 (43.5%) was predominant among foreign nationals. The most common CRFs were CRF02_AG (3.8%) and CRF56_cpx (1.6%). According to the change in detection rates during the study period, Subtype B decreased, and Subtype A increased. The most frequent mutations detected were A62V (38.7%) and M184V (22.4%) for NRTIs; E138A (55.5%) and E138G (11.5%) for NNRTIs; M46I (33.3%) and M46L (25%) for PIs; and E92Q and G for INIs (total rate: 35.2%). Darunavir/ritonavir had the highest sensitivity rate, while resistance rates for NNRTIs and INIs increased over time. We anticipate that this study, in which we evaluate the routine use of an FDA-approved NGS kit alongside integrated bioinformatics data analysis and automated reporting software for the first time in Türkiye, will contribute to both national and international molecular epidemiological data and public health strategies by providing reliable results that align with international standarts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Drug Resistance, ViralHIV InfectionsMutationAnti-HIV AgentsHumansHigh-Throughput Nucleotide SequencingTurkeyMaleFemaleAdultMiddle AgedRetrospective StudiesGenotypeYoung Adult

Stichwörter der Autor:innen

HIV-1 mutations and subtypesantiretroviral drug resistancehuman immunodeficiency virusnext-generation sequencing

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Medical Microbiology, Marmara University Pendik Research and Training Hospital, Istanbul 34899, Türkiye.
  • Medical Microbiology, Fatih Sultan Mehmet Research and Training Hospital, Istanbul 34752, Türkiye.
  • Medical Microbiology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul 34865, Türkiye.
  • Department of Medical Microbiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul 34093, Türkiye.
  • Department of Medical Microbiology, Faculty of Medicine, Marmara University, Istanbul 3484, Türkiye.

ORCID-Profile: Murat Yaman, Begüm Saran Gülcen, Kübra Özgüler, Muammer Osman Köksal, Serap Demir Tekol, Arzu İlki

Zitieren

APA

Yaman, M., Gülcen, B. S., Özgüler, K., Köksal, M. O., Tekol, S. D., & İlki, A. (2025). Temporal Trends in HIV-1 Subtypes and Antiretroviral Drug Resistance Mutations in Istanbul, Türkiye (2021–2024): A Next-Generation Sequencing Study. Viruses. https://doi.org/10.3390/v17040478

Vancouver

Yaman M, Gülcen BS, Özgüler K, Köksal MO, Tekol SD, İlki A. Temporal Trends in HIV-1 Subtypes and Antiretroviral Drug Resistance Mutations in Istanbul, Türkiye (2021–2024): A Next-Generation Sequencing Study. Viruses. 2025. doi:10.3390/v17040478

BibTeX
@article{Yaman2025,
  author = {Yaman, Murat and Gülcen, Begüm Saran and Özgüler, Kübra and Köksal, Muammer Osman and Tekol, Serap Demir and İlki, Arzu},
  title = {Temporal Trends in HIV-1 Subtypes and Antiretroviral Drug Resistance Mutations in Istanbul, Türkiye (2021–2024): A Next-Generation Sequencing Study},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17040478}
}
Kostenlos starten →